[1] A.I. Caplan, Mesenchymal stem cells, Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 9 (1991) 641-650.
[2] P. Bianco, P.G. Robey, P.J. Simmons, Mesenchymal stem cells: revisiting history, concepts, and assays, Cell Stem Cell, 2 (2008) 313-319.
[3] J. Galipeau, L. Sensebe, Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities, Cell Stem Cell, 22 (2018) 824-833.
[4] K. Le Blanc, O. Ringden, Immunomodulation by mesenchymal stem cells and clinical experience, J Intern Med, 262 (2007) 509-525.
[5] E. Eggenhofer, V. Benseler, A. Kroemer, F.C. Popp, E.K. Geissler, H.J. Schlitt, C.C. Baan, M.H. Dahlke, M.J. Hoogduijn, Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion, Front Immunol, 3 (2012) 297.
[6] S.F.H. de Witte, F. Luk, J.M. Sierra Parraga, M. Gargesha, A. Merino, S.S. Korevaar, A.S. Shankar, L. O'Flynn, S.J. Elliman, D. Roy, M.G.H. Betjes, P.N. Newsome, C.C. Baan, M.J. Hoogduijn, Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells, Stem Cells, 36 (2018) 602-615.
[7] A. Galleu, Y. Riffo-Vasquez, C. Trento, C. Lomas, L. Dolcetti, T.S. Cheung, M. von Bonin, L. Barbieri, K. Halai, S. Ward, L. Weng, R. Chakraverty, G. Lombardi, F.M. Watt, K. Orchard, D.I. Marks, J. Apperley, M. Bornhauser, H. Walczak, C. Bennett, F. Dazzi, Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation, Science translational medicine, 9 (2017).
[8] T. Thum, J. Bauersachs, P.A. Poole-Wilson, H.D. Volk, S.D. Anker, The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle, J Am Coll Cardiol, 46 (2005) 1799-1802.
[9] P.-H. Sung, C.-L. Chang, T.-H. Tsai, L.-T. Chang, S. Leu, Y.-L. Chen, C.-C. Yang, S. Chua, K.-H. Yeh, H.-T. Chai, H.-W. Chang, H.-H. Chen, H.-K. Yip, Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats, Stem Cell Research & Therapy, 4 (2013) 155.
[10] A.R.R. Weiss, M.H. Dahlke, Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs, Front Immunol, 10 (2019) 1191.
[11] R. Kakarla, J. Hur, Y.J. Kim, J. Kim, Y.J. Chwae, Apoptotic cell-derived exosomes: messages from dying cells, Exp Mol Med, 52 (2020) 1-6.
[12] S. Caruso, I.K.H. Poon, Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris, Front Immunol, 9 (2018) 1486.
[13] V. Agrahari, V. Agrahari, P.A. Burnouf, C.H. Chew, T. Burnouf, Extracellular Microvesicles as New Industrial Therapeutic Frontiers, Trends Biotechnol, 37 (2019) 707-729.
[14] W. Zhu, W. Xu, R. Jiang, H. Qian, M. Chen, J. Hu, W. Cao, C. Han, Y. Chen, Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo, Exp Mol Pathol, 80 (2006) 267-274.
[15] F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noel, C. Jorgensen, Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals, Blood, 102 (2003) 3837-3844.
[16] Y. Shi, L. Du, L. Lin, Y. Wang, Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets, Nat Rev Drug Discov, 16 (2017) 35-52.
[17] E.L. Spaeth, J.L. Dembinski, A.K. Sasser, K. Watson, A. Klopp, B. Hall, M. Andreeff, F. Marini, Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression, PloS one, 4 (2009) e4992.
[18] P.J. Mishra, P.J. Mishra, R. Humeniuk, D.J. Medina, G. Alexe, J.P. Mesirov, S. Ganesan, J.W. Glod, D. Banerjee, Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells, Cancer Research, 68 (2008) 4331-4339.
[19] A. Adamo, G. Dal Collo, R. Bazzoni, M. Krampera, Role of mesenchymal stromal cell-derived extracellular vesicles in tumour microenvironment, Biochim Biophys Acta Rev Cancer, 1871 (2019) 192-198.
[20] S. Bruno, F. Collino, A. Iavello, G. Camussi, Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth, Front Immunol, 5 (2014) 382.
[21] T.S. Cheung, A. Galleu, M. von Bonin, M. Bornhäuser, F. Dazzi, Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity, Haematologica, 104 (2019) e438-e441.
[22] V.V. Mozhaev, K. Heremans, J. Frank, P. Masson, C. Balny, Exploiting the effects of high hydrostatic pressure in biotechnological applications, Trends in Biotechnology, 12 (1994) 493-501.
[23] B. Frey, S. Franz, A. Sheriff, A. Korn, G. Bluemelhuber, U.S. Gaipl, R.E. Voll, R. Meyer-Pittroff, M. Herrmann, Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis, Cellular and molecular biology (Noisy-le-Grand, France), 50 (2004) 459-467.
[24] A. Aertsen, F. Meersman, M.E. Hendrickx, R.F. Vogel, C.W. Michiels, Biotechnology under high pressure: applications and implications, Trends Biotechnol, 27 (2009) 434-441.
[25] N. Rivalain, J. Roquain, G. Demazeau, Development of high hydrostatic pressure in biosciences: pressure effect on biological structures and potential applications in biotechnologies, Biotechnol Adv, 28 (2010) 659-672.
[26] A. Isidan, S. Liu, P. Li, M. Lashmet, L.J. Smith, H. Hara, D.K.C. Cooper, B. Ekser, Decellularization methods for developing porcine corneal xenografts and future perspectives, Xenotransplantation, 26 (2019) e12564.
[27] C.A. Belmokhtar, J. Hillion, E. Ségal-Bendirdjian, Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms, Oncogene, 20 (2001) 3354.
[28] J. Leibacher, K. Dauber, S. Ehser, V. Brixner, K. Kollar, A. Vogel, G. Spohn, R. Schafer, E. Seifried, R. Henschler, Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice, Cytotherapy, 19 (2017) 61-74.
[29] T. Mitsui, N. Morimoto, A. Mahara, S.C. Notodihardjo, T.M. Le, M.C. Munisso, M. Moriyama, H. Moriyama, N. Kakudo, T. Yamaoka, K. Kusumoto, Exploration of the Pressurization Condition for Killing Human Skin Cells and Skin Tumor Cells by High Hydrostatic Pressure, BioMed Research International, 2020 (2020) 1-17.
[30] S. Johnson, V. Nguyen, D. Coder, Assessment of cell viability, Curr Protoc Cytom, Chapter 9 (2013) Unit9 2.
[31] T.L. Riss, R.A. Moravec, A.L. Niles, S. Duellman, H.A. Benink, T.J. Worzella, L. Minor, Cell Viability Assays, in: G.S. Sittampalam, N.P. Coussens, K. Brimacombe, A. Grossman, M. Arkin, D. Auld, C. Austin, J. Baell, B. Bejcek, J.M.M. Caaveiro, T.D.Y. Chung, J.L. Dahlin, V. Devanaryan, T.L. Foley, M. Glicksman, M.D. Hall, J.V. Haas, J. Inglese, P.W. Iversen, S.D. Kahl, S.C. Kales, M. Lal-Nag, Z. Li, J. McGee, O. McManus, T. Riss, O.J. Trask, Jr., J.R. Weidner, M.J. Wildey, M. Xia, X. Xu (Eds.) Assay Guidance Manual, Bethesda (MD), 2016.
[32] K. Chamchoy, D. Pakotiprapha, P. Pumirat, U. Leartsakulpanich, U. Boonyuen, Application of WST-8 based colorimetric NAD(P)H detection for quantitative dehydrogenase assays, BMC Biochemistry, 20 (2019).
[33] A. Mahara, N. Morimoto, T. Sakuma, T. Fujisato, T. Yamaoka, Complete cell killing by applying high hydrostatic pressure for acellular vascular graft preparation, Biomed Res Int, 2014 (2014) 379607.
[34] A. Tinari, A.M. Giammarioli, V. Manganelli, L. Ciarlo, W. Malorni, Analyzing morphological and ultrastructural features in cell death, Methods Enzymol, 442 (2008) 1-26.
[35] L. Galluzzi, I. Vitale, Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018, Cell death and differentiation, 25 (2018) 486-541.
[36] S. Elmore, Apoptosis: A Review of Programmed Cell Death, Toxicologic pathology, 35 (2007) 495-516.
[37] M.K. White, C. Cinti, A morphologic approach to detect apoptosis based on electron microscopy, Methods in molecular biology (Clifton, N.J.), 285 (2004) 105-111.
[38] V. Nikoletopoulou, M. Markaki, K. Palikaras, N. Tavernarakis, Crosstalk between apoptosis, necrosis and autophagy, Biochim Biophys Acta, 1833 (2013) 3448-3459.
[39] Y. Tsujimoto, S. Shimizu, Another way to die: autophagic programmed cell death, Cell death and differentiation, 12 Suppl 2 (2005) 1528-1534.
[40] U. Ziegler, P. Groscurth, Morphological features of cell death, News Physiol Sci, 19 (2004) 124-128.
[41] K. Segawa, S. Kurata, Y. Yanagihashi, T.R. Brummelkamp, F. Matsuda, S. Nagata, Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure, Science, 344 (2014) 1164-1168.
[42] D.T. Loo, In situ detection of apoptosis by the TUNEL assay: an overview of techniques, Methods in molecular biology (Clifton, N.J.), 682 (2011) 3-13.
[43] C.D. Bortner, N.B.E. Oldenburg, J.A. Cidlowski, The role of DNA fragmentation in apoptosis, Trends in Cell Biology, 5 (1995) 21-26.
[44] T. Yamaguchi, K. Hashiguchi, S. Katsuki, W. Iwamoto, S. Tsuruhara, S. Terada, Activation of the intrinsic and extrinsic pathways in high pressure-induced apoptosis of murine erythroleukemia cells, Cell Mol Biol Lett, 13 (2008) 49-57.
[45] S. Nagata, J. Suzuki, K. Segawa, T. Fujii, Exposure of phosphatidylserine on the cell surface, Cell death and differentiation, 23 (2016) 952-961.
[46] L. Galluzzi, M.C. Maiuri, I. Vitale, H. Zischka, M. Castedo, L. Zitvogel, G. Kroemer, Cell death modalities: classification and pathophysiological implications, Cell death and differentiation, 14 (2007) 1237-1243.
[47] M. Watanabe, M. Hitomi, K. van der Wee, F. Rothenberg, S.A. Fisher, R. Zucker, K.K. Svoboda, E.C. Goldsmith, K.M. Heiskanen, A.L. Nieminen, The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs, Microsc Microanal, 8 (2002) 375-391.
[48] M.R. Elliott, K.S. Ravichandran, The Dynamics of Apoptotic Cell Clearance, Dev Cell, 38 (2016) 147-160.
[49] J. Chen, Z. Liu, M.M. Hong, H. Zhang, C. Chen, M. Xiao, J. Wang, F. Yao, M. Ba, J. Liu, Z.K. Guo, J. Zhong, Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cells, PloS one, 9 (2014) e115316.
[50] S. Rani, A.E. Ryan, M.D. Griffin, T. Ritter, Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications, Mol Ther, 23 (2015) 812-823.